⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL27878723 | 0.97 | — | — | |
| SCHEMBL5713342 | 0.83 | NOS1 (0.34) | — | |
| SCHEMBL6022879 | 0.81 | — | — | |
| SCHEMBL3477581 | 0.79 | — | — | |
| SCHEMBL508211 | 0.79 | — | — | |
| SCHEMBL23666770 | 0.79 | — | — | |
| SCHEMBL11152177 | 0.79 | — | — | |
| SCHEMBL6017694 | 0.79 | — | — | |
| SCHEMBL25845213 | 0.79 | — | — | |
| SCHEMBL9963226 | 0.79 | NOS1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1985 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368635-A1 | HETEROARYL DERIVATIVE COMPOUND, AND USES THEREOF | VORONOI, INC. (KR) | 2025-12-04 | — | — | US | claimed |
| CN-118812508-A | 1-Isopropyl-1H-pyrazole compound, pharmaceutical composition and application | 原研药港生命科学研究(辽宁)有限公司 | 2024-10-22 | — | — | CN | claimed |
| WO-2024207777-A1 | 1-ISOPROPYL-1H-PYRAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION AND USE | 原研药港生命科学研究(辽宁)有限公司 | 2024-10-10 | — | — | WO | claimed |
| US-20240254103-A9 | NOVEL PYRIMIDINE DERIVATIVE, AND COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES AND CANCER, COMPRISING SAME | WHAN IN PHARMACEUTICAL CO., LTD. (KR) | 2024-08-01 | — | — | US | claimed |
| US-20230219930-A1 | NOVEL PYRIMIDINE DERIVATIVE, AND COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES AND CANCER, COMPRISING SAME | WHAN IN PHARMACEUTICAL CO., LTD. (KR) | 2023-07-13 | — | — | US | claimed |
| US-20230027361-A1 | METTL3 MODULATORS | ACCENT THERAPEUTICS, INC. (US) | 2023-01-26 | — | — | US | claimed |
| CN-115298179-A | METTL3 modulators | 埃克森特治疗公司 | 2022-11-04 | — | — | CN | claimed |
| WO-2021079196-A9 | METTL3 MODULATORS | ACCENT THERAPEUTICS, INC (US) | 2022-07-14 | — | — | WO | claimed |
| CN-109456200-B | Preparation method of m-xylylenediamine | 万华化学集团股份有限公司 | 2021-07-23 | — | — | CN | claimed |
| WO-2021079196-A2 | METTL3 MODULATORS | ACCENT THERAPEUTICS, INC (US) | 2021-04-29 | — | — | WO | claimed |
| US-20140315959-A1 | TREATMENT OF OVARIAN CANCER WITH BENZYLIDENEBENZOHYDRAZIDES | MEMORIAL SLOAN-KETTERING CANCER CENTER | 2014-10-23 | — | — | US | claimed |
| US-20140294805-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO EARLY DISCOVERY, INC. | 2014-10-02 | — | — | US | claimed |
| EP-2776029-A1 | TREATMENT OF OVARIAN CANCER WITH BENZYLIDENEBENZOHYDRAZIDES | Memorial Sloan-Kettering Cancer Center (US) | 2014-09-17 | — | — | EP | claimed |
| EP-2611804-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | Forma TM, LLC. (US) | 2013-07-10 | — | — | EP | claimed |
| WO-2013071001-A1 | TREATMENT OF OVARIAN CANCER WITH BENZYLIDENEBENZOHYDRAZIDES | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2013-05-16 | — | — | WO | claimed |
| WO-2012031197-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | FORMA THERAPEUTICS, INC. (US) | 2012-03-08 | — | — | WO | claimed |
| WO-2010142493-A2 | AFTERTREATMENT FOR COLOR FIXATION | HENKEL AG & CO. KGAA (DE) | 2010-12-16 | — | — | WO | claimed |
| US-RE33907-E | Anti-spasmodic agents having a heterocyclic ring | UNITED PHARMACEUTICALS, INC. (US) | 1992-04-28 | — | — | US | claimed |
| US-4857535-A | THIOESTERS | UNITED PHARMACEUTICALS (US) | 1989-08-15 | — | — | US | claimed |
| US-4721783-A | SMOOTH MUSCLES | UNITED PHARMACEUTICALS, INC. (US) | 1988-01-26 | — | — | US | claimed |